2010 ~ 2019
“ Korean Drug Co. Ltd is a company
that challenges the future with unprecedented growth and development”
2019 |
Nov. Designation as a company applying good manufacturing practice (GMP) for health functional food. |
---|---|
2016 |
Jul. National research funding of KRW 550 million for development of new functional food ingredients in the use of Portulaca extracts. |
2015 |
Nov. Investment of 5% in share of "DIAMESCO Co, Ltd.', digital insulin pen development company. Sept. National research funding of KRW 1.2 billion for atopic dermatitis research. |
2014 |
Jul. Selection of the Agricultural biotechnology development business with utilizing common sage for osteoporosis treatment business, national research funding of KRW 5 billion |